Combination of SiRNA-directed Gene Silencing with Epigallocatechin-3-gallate (EGCG) Reverses Drug Resistance in Human Breast Cancer Cells

Overview

Journal J Chem Biol

Specialty Biochemistry

Date 2016 Feb 9

PMID 26855680

Citations 22

Authors

Mohammad Ali Esmaeili

Affiliations

Soon will be listed here.

Abstract

Elevated expression of NF-E2-related factor 2 (Nrf2), a nuclear transcription factor, is a frequent genetic abnormality seen in this malignancy and is an important contributor to chemoresistance in cancer therapy. In the present study, we investigated if Nrf2 was associated with drug resistance in tamoxifen-resistant MCF-7 (MCF-7/TAM) cells, and whether EGCG, major flavonoid isolated from green tea, could reverse drug resistance in MCF-7/TAM cells. Our results showed that the endogenous expression of Nrf2 as well as its target proteins heme oxygenase-1, NADP (H):quinone oxidoreductase in MCF-7/TAM cells was higher than that in MCF-7 cells. Epicatechin gallate (EGCG) significantly sensitizes MCF-7/TAM cells to tamoxifen and dramatically reduced Nrf2 expression at both the messenger RNA and protein, leading to a reduction of Nrf2-downstream genes. In addition, using siRNA technique, we found that the intracellular Nrf2 protein level was significantly decreased in MCF-7/TAM cells and tamoxifen resistance was partially reversed by Nrf2 siRNA. Combination of siRNA-directed gene silencing with EGCG downregulated the Nrf2-dependent response and partly reversed tamoxifen resistance in MCF-7/TAM cells in a synergic manner. These results suggested that combining the chemotherapeutic effect of EGCG with siRNA-mediated Nrf2 knock-down results in the feasibility of using Nrf2 inhibitors to increase efficacy of chemotherapeutic drugs.

Citing Articles

NRF2 Modulators of Plant Origin and Their Ability to Overcome Multidrug Resistance in Cancers.

Wadowski P, Juszczak M, Wozniak K Int J Mol Sci. 2024; 25(21).

PMID: 39519053 PMC: 11547051. DOI: 10.3390/ijms252111500.

Therapeutic delivery of siRNA for the management of breast cancer and triple-negative breast cancer.

Sai B, Dinakar Y, Kumar H, Jain R, Kesharwani S, Kesharwani S Ther Deliv. 2024; 15(11):871-891.

PMID: 39320858 PMC: 11498026. DOI: 10.1080/20415990.2024.2400044.

The Involvement of Peroxiporins and Antioxidant Transcription Factors in Breast Cancer Therapy Resistance.

Milkovic L, Mlinaric M, Lucic I, cipak Gasparovic A Cancers (Basel). 2023; 15(24).

PMID: 38136293 PMC: 10741870. DOI: 10.3390/cancers15245747.

NRF2 Suppression Enhances the Susceptibility of Pancreatic Cancer Cells, Miapaca-2 to Paclitaxel.

Riazi-Tabrizi N, Khalaj-Kondori M, Safaei S, Amini M, Hassanian H, Maghsoudi M Mol Biotechnol. 2023; 66(9):2441-2454.

PMID: 37740817 DOI: 10.1007/s12033-023-00872-2.

Cellular Stress Response (Hormesis) in Response to Bioactive Nutraceuticals with Relevance to Alzheimer Disease.

Butterfield D, Boyd-Kimball D, Reed T Antioxid Redox Signal. 2023; 38(7-9):643-669.

PMID: 36656673 PMC: 10025851. DOI: 10.1089/ars.2022.0214.

References

Jaiswal A . Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med. 2004; 36(10):1199-207. DOI: 10.1016/j.freeradbiomed.2004.02.074. View

Berindan-Neagoe I, Braicu C, Irimie A . Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effects. Int J Nanomedicine. 2012; 7:6035-47. PMC: 3525046. DOI: 10.2147/IJN.S36523. View

Kweon M, Adhami V, Lee J, Mukhtar H . Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J Biol Chem. 2006; 281(44):33761-72. DOI: 10.1074/jbc.M604748200. View

Vollrath V, Wielandt A, Iruretagoyena M, Chianale J . Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene. Biochem J. 2006; 395(3):599-609. PMC: 1462684. DOI: 10.1042/BJ20051518. View

Katiyar S, Mukhtar H . Inhibition of phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate-caused inflammatory responses in SENCAR mouse skin by black tea polyphenols. Carcinogenesis. 1997; 18(10):1911-6. DOI: 10.1093/carcin/18.10.1911. View

Wang X, Sun Z, Villeneuve N, Zhang S, Zhao F, Li Y . Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis. 2008; 29(6):1235-43. PMC: 3312612. DOI: 10.1093/carcin/bgn095. View

Enomoto A, Itoh K, Nagayoshi E, Haruta J, Kimura T, OConnor T . High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol Sci. 2001; 59(1):169-77. DOI: 10.1093/toxsci/59.1.169. View

Rose C, Thorpe S, ANDERSEN K, Pedersen B, Mouridsen H, Blichert-Toft M . Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. Lancet. 1985; 1(8419):16-9. DOI: 10.1016/s0140-6736(85)90966-3. View

Inoue M, Tajima K, Hirose K, Hamajima N, Takezaki T, Kuroishi T . Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case-referent study in Japan. Cancer Causes Control. 1998; 9(2):209-16. DOI: 10.1023/a:1008890529261. View

10.

Chan J, Kwong M . Impaired expression of glutathione synthetic enzyme genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein. Biochim Biophys Acta. 2000; 1517(1):19-26. DOI: 10.1016/s0167-4781(00)00238-4. View

11.

Farabegoli F, Papi A, Bartolini G, Ostan R, Orlandi M . (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line. Phytomedicine. 2010; 17(5):356-62. DOI: 10.1016/j.phymed.2010.01.001. View

12.

Paglia D, Valentine W . Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967; 70(1):158-69. View

13.

Ohnuma T, Matsumoto T, Itoi A, Kawana A, Nishiyama T, Ogura K . Enhanced sensitivity of A549 cells to the cytotoxic action of anticancer drugs via suppression of Nrf2 by procyanidins from Cinnamomi Cortex extract. Biochem Biophys Res Commun. 2011; 413(4):623-9. DOI: 10.1016/j.bbrc.2011.09.014. View

14.

Jiang T, Chen N, Zhao F, Wang X, Kong B, Zheng W . High levels of Nrf2 determine chemoresistance in type II endometrial cancer. Cancer Res. 2010; 70(13):5486-96. PMC: 2896449. DOI: 10.1158/0008-5472.CAN-10-0713. View

15.

Itoh K, Tong K, Yamamoto M . Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med. 2004; 36(10):1208-13. DOI: 10.1016/j.freeradbiomed.2004.02.075. View

16.

Duthie S, Melvin W, Burke M . Drug toxicity mechanisms in human hepatoma HepG2 cells: cyclosporin A and tamoxifen. Xenobiotica. 1995; 25(10):1151-64. DOI: 10.3109/00498259509061915. View

17.

Park S, Ito K, Olcott W, Katsyv I, Halstead-Nussloch G, Irie H . PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim. Breast Cancer Res. 2015; 17:86. PMC: 4496943. DOI: 10.1186/s13058-015-0594-z. View

18.

Kim S, Yang J, Kim M, Roh S, Kim H, Lee K . Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells. Free Radic Biol Med. 2008; 45(4):537-46. DOI: 10.1016/j.freeradbiomed.2008.05.011. View

19.

Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y . Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res. 1998; 89(3):254-61. PMC: 5921805. DOI: 10.1111/j.1349-7006.1998.tb00556.x. View

20.

Gottardis M, Jordan V . Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration. Cancer Res. 1988; 48(18):5183-7. View